• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回肠黏膜相关微生物群中产生丁酸的细菌减少与克罗恩病患者腹部手术史有关。

Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn's disease.

机构信息

Department of Gastroenterology and Hepatology, Kawasaki Medical School, Kurashiki, Okayama, Japan.

Faculty of Agriculture, Setsunan University, Hirakata-city, Osaka, Japan.

出版信息

Redox Rep. 2023 Dec;28(1):2241615. doi: 10.1080/13510002.2023.2241615.

DOI:10.1080/13510002.2023.2241615
PMID:37530134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10402863/
Abstract

Fecal microbiota is a significant factor determining the cause, course, and prognosis of Crohn's disease (CD). However, the factors affecting mucosa-associated microbiota (MAM) remain unclear. This retrospective study examined the differences in ileal MAM between CD patients and healthy controls and investigated the factors affecting MAM in CD patients to clarify potential therapeutic targets. Ileal MAM was obtained using brush forceps during endoscopic examination from 23 healthy controls and 32 CD patients (most were in remission). The samples' microbiota was profiled using the Illumina MiSeq platform. Compared to controls, CD patients had significantly reduced -diversity in the ileum and a difference in -diversity. The abundance of butyric acid-producing bacteria in the ileal MAM was significantly lower in CD patients with a history of abdominal surgery than in those without. Because butyric acid is a major energy source in the intestinal epithelium, its metabolism via β-oxidation increases oxygen consumption in epithelial cells, reducing oxygen concentration in the intestinal lumen and increasing the abundance of obligate anaerobic bacteria. The suppression of obligate anaerobes in CD patients caused an overgrowth of facultative anaerobes. Summarily, reducing the abundance of butyric acid-producing bacteria in the ileal MAM may play an important role in CD pathophysiology.

摘要

肠道微生物群是决定克罗恩病(CD)病因、病程和预后的重要因素。然而,影响黏膜相关微生物群(MAM)的因素尚不清楚。本回顾性研究旨在比较 CD 患者和健康对照者回肠 MAM 的差异,并探讨影响 CD 患者 MAM 的因素,以明确潜在的治疗靶点。通过内镜检查用毛刷从 23 名健康对照者和 32 名 CD 患者(大多数处于缓解期)回肠中获取 MAM 样本。采用 Illumina MiSeq 平台对样本的微生物组进行分析。与对照组相比,CD 患者回肠的 -多样性显著降低,且 -多样性存在差异。与无腹部手术史的 CD 患者相比,有腹部手术史的 CD 患者回肠 MAM 中产生丁酸的细菌丰度显著降低。由于丁酸是肠上皮的主要能量来源,其通过β-氧化代谢增加上皮细胞的耗氧量,降低肠腔中的氧浓度,增加专性厌氧菌的丰度。CD 患者中专性厌氧菌的抑制导致兼性厌氧菌过度生长。总之,回肠 MAM 中产生丁酸的细菌丰度降低可能在 CD 的病理生理学中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b2/10402863/4aee3fa4e88d/YRER_A_2241615_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b2/10402863/418eb9c2f39d/YRER_A_2241615_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b2/10402863/4aee3fa4e88d/YRER_A_2241615_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b2/10402863/418eb9c2f39d/YRER_A_2241615_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b2/10402863/4aee3fa4e88d/YRER_A_2241615_F0002_OC.jpg

相似文献

1
Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn's disease.回肠黏膜相关微生物群中产生丁酸的细菌减少与克罗恩病患者腹部手术史有关。
Redox Rep. 2023 Dec;28(1):2241615. doi: 10.1080/13510002.2023.2241615.
2
Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease.克罗恩病患者炎症性和近端非炎症性回肠的细菌黏膜相关微生物组。
Inflamm Bowel Dis. 2021 Jan 1;27(1):12-24. doi: 10.1093/ibd/izaa107.
3
Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.克罗恩病切除时特定黏膜相关微生物群与随后疾病复发之间的关联:一项初步研究。
J Gastroenterol Hepatol. 2015 Feb;30(2):268-78. doi: 10.1111/jgh.12694.
4
Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients.溃疡性结肠炎患者回肠黏膜相关微生物群中丁酸产生菌的丰度降低。
J Clin Biochem Nutr. 2023 Jul;73(1):77-83. doi: 10.3164/jcbn.22-86. Epub 2023 Apr 14.
5
Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease.回肠黏膜相关微生物群对预测克罗恩病术后内镜复发的重要性。
Gut. 2020 Mar;69(3):462-472. doi: 10.1136/gutjnl-2019-318719. Epub 2019 May 29.
6
Crohn's Disease Differentially Affects Region-Specific Composition and Aerotolerance Profiles of Mucosally Adherent Bacteria.克罗恩病对黏附于黏膜的细菌的区域特异性组成和需氧耐受特性有差异影响。
Inflamm Bowel Dis. 2020 Nov 19;26(12):1843-1855. doi: 10.1093/ibd/izaa103.
7
Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.克罗恩病治疗过程中黏膜相关肠道微生物群的特征。
World J Gastroenterol. 2019 May 14;25(18):2204-2216. doi: 10.3748/wjg.v25.i18.2204.
8
Association of Adherent-invasive with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn's disease.香港克罗恩病患者中,黏附侵袭性与严重肠道黏膜菌群失调相关。
Gut Microbes. 2021 Jan-Dec;13(1):1994833. doi: 10.1080/19490976.2021.1994833.
9
IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.IL23R 保护性编码变异促进健康个体回肠微生物组中有益细菌和多样性,而不会引起炎症性肠病。
J Crohns Colitis. 2019 Mar 30;13(4):451-461. doi: 10.1093/ecco-jcc/jjy188.
10
Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease.新发小儿克罗恩病的回肠黏膜相关微生物群
Inflamm Bowel Dis. 2016 Jul;22(7):1533-9. doi: 10.1097/MIB.0000000000000776.

引用本文的文献

1
The Role of Gut Microbiota on Intestinal Fibrosis in Inflammatory Bowel Disease and Traditional Chinese Medicine Intervention.肠道微生物群在炎症性肠病肠道纤维化中的作用及中医药干预
J Inflamm Res. 2025 May 7;18:5951-5967. doi: 10.2147/JIR.S504827. eCollection 2025.
2
Effect of Coptidis Rhizoma on gastrointestinal system before and after processing with wine based on gut microbiota and short chain fatty acids.基于肠道微生物群和短链脂肪酸探讨黄连酒制前后对胃肠系统的影响
Front Pharmacol. 2024 Nov 18;15:1492047. doi: 10.3389/fphar.2024.1492047. eCollection 2024.
3
Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment.

本文引用的文献

1
Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).日本克罗恩病全国起始队列登记研究(iCREST-CD)中初诊成人克罗恩病患者的特征:中期分析。
J Gastroenterol. 2022 Nov;57(11):867-878. doi: 10.1007/s00535-022-01907-2. Epub 2022 Aug 5.
2
Bacterial Community Structure and Potential Microbial Coexistence Mechanism Associated with Three Halophytes Adapting to the Extremely Hypersaline Environment.与三种适应极端高盐环境的盐生植物相关的细菌群落结构及潜在微生物共存机制
Microorganisms. 2022 May 30;10(6):1124. doi: 10.3390/microorganisms10061124.
3
炎症性肠病中的脂肪酸和脂质介质:从机制到治疗。
Front Immunol. 2023 Oct 5;14:1286667. doi: 10.3389/fimmu.2023.1286667. eCollection 2023.
Comparison of mucosa-associated microbiota in Crohn's disease patients with and without anti-tumor necrosis factor-α therapy.
接受和未接受抗肿瘤坏死因子-α治疗的克罗恩病患者黏膜相关微生物群的比较。
J Clin Biochem Nutr. 2022 Mar;70(2):182-188. doi: 10.3164/jcbn.21-41. Epub 2021 Sep 25.
4
Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study.与抗 TNF 生物制剂相比,乌司奴单抗治疗克罗恩病和维得利珠单抗治疗溃疡性结肠炎的持续治疗效果更好:来自真实世界的澳大利亚国家 IBD 队列(PANIC)研究的持久性注册数据。
Aliment Pharmacol Ther. 2021 Aug;54(3):292-301. doi: 10.1111/apt.16436. Epub 2021 Jun 20.
5
Self-Assembling Antioxidants for Ischemia-Reperfusion Injuries.自组装抗氧化剂治疗缺血再灌注损伤。
Antioxid Redox Signal. 2022 Jan;36(1-3):70-80. doi: 10.1089/ars.2021.0103. Epub 2021 Sep 7.
6
Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts.基于人群队列的荟萃分析:溃疡性结肠炎和克罗恩病患者的当代手术风险。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2031-2045.e11. doi: 10.1016/j.cgh.2020.10.039. Epub 2020 Oct 27.
7
The four epidemiological stages in the global evolution of inflammatory bowel disease.炎症性肠病全球演变的四个流行病学阶段。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):56-66. doi: 10.1038/s41575-020-00360-x. Epub 2020 Oct 8.
8
Effectiveness of including probiotics to eradication therapies.在根除治疗中加入益生菌的有效性。
J Clin Biochem Nutr. 2020 Jul;67(1):102-104. doi: 10.3164/jcbn.20-37. Epub 2020 Jun 5.
9
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease.氧化应激与炎症性肠病的氧化还原调节治疗。
Trends Mol Med. 2020 Nov;26(11):1034-1046. doi: 10.1016/j.molmed.2020.06.006. Epub 2020 Jun 30.
10
Small Bowel Healing Detected by Endoscopy in Patients With Crohn's Disease After Treatment With Antibodies Against Tumor Necrosis Factor.内镜下观察抗 TNF 抗体治疗后克罗恩病患者的小肠愈合情况。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1545-1552. doi: 10.1016/j.cgh.2019.08.024. Epub 2019 Aug 20.